A systematic review of primary active surveillance management of low-risk papillary carcinoma

被引:19
|
作者
Alhashemi, Ahmad [1 ]
Goldstein, David P. [2 ,3 ]
Sawka, Anna M. [1 ,4 ]
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada
关键词
active surveillance; papillary thyroid cancer; thyroid carcinoma; thyroidectomy; DIFFERENTIATED THYROID-CARCINOMA; THERAPEUTIC STRATEGY; ENDOCRINE SURGEONS; SURGICAL-TREATMENT; JAPANESE SOCIETY; UNITED-STATES; PATIENT AGE; CANCER; MICROCARCINOMA; ASSOCIATION;
D O I
10.1097/CCO.0000000000000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Active surveillance is close follow-up of neoplasms, with predetermined intervention triggers. We systematically reviewed the published English language literature on primary active surveillance of low-risk papillary thyroid cancer (PTC). Recent findings We searched seven electronic databases (1980-2015), supplemented with a hand search. Two reviewers independently screened 1715 citations and reviewed 32 full-text papers, ultimately including two papers. Data were independently abstracted. There were two Japanese single-center, single-arm studies reporting on 1235 and 322 patients with PTC microcarcinoma (primary <1 cm in diameter) confined to the thyroid. Mean study follow-up was of 5.0 and 6.5 years, respectively. Disease triggers for thyroidectomy included progression of the primary tumor or incident metastatic disease. The rates of thyroidectomy were 15.5% (191/1235) and 8.7% (28/322) in respective studies. The incidence of primary tumor enlargement >= 3 mm in maximal diameter was 4.6% (58/1235) and 5.0% (16/322). The incidence of nodal metastases was 1.5% (19/1235) and 0.9% (3/322). There were neither reports of PTC-related death nor development of distant metastatic disease. Quality of life, psychosocial health, and economic outcomes were not reported. Summary In two Japanese single-arm studies, active surveillance of PTC microcarcinoma was relatively well tolerated; however, more long-term outcome research is needed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [1] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
    Smulever, Anabella
    Pitoia, Fabian
    THYROID RESEARCH, 2023, 16 (01)
  • [2] Outcomes and effectiveness of active surveillance for low-risk papillary thyroid carcinoma: a systematic review and meta-analysis
    Nguyen, Van Cuong
    Song, Chang Myeon
    Ji, Yong Bae
    Moon, Shinje
    Park, Jung Hwan
    Kim, Dong Sun
    Tae, Kyung
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, : 2239 - 2252
  • [3] Active Surveillance for Low-Risk Papillary Thyroid Carcinoma as an Acceptable Management Option with Additional Benefits: A Comprehensive Systematic Review
    Yoon, Jee Hee
    Choi, Wonsuk
    Park, Ji Yong
    Hong, A. Ram
    Kim, Hee Kyung
    Kang, Ho-Cheol
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 152 - 163
  • [4] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
    Anabella Smulever
    Fabian Pitoia
    Thyroid Research, 16
  • [5] Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
    Ito, Y.
    Miyauchi, A.
    Oda, H.
    EJSO, 2018, 44 (03): : 307 - 315
  • [6] Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
    Ding, Wu
    Ruan, Guodong
    Lin, Yingli
    Zhu, Jianming
    Li, Zhian
    Ye, Dengfeng
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [7] Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance
    Ramone, Teresa
    Ghirri, Arianna
    Prete, Alessandro
    Matrone, Antonio
    Ciampi, Raffaele
    Piaggi, Paolo
    Scutari, Maria
    Rago, Teresa
    Torregrossa, Liborio
    Romei, Cristina
    Elisei, Rossella
    Molinaro, Eleonora
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, : 685 - 692
  • [8] Active surveillance of low-risk papillary thyroid carcinoma: a promising strategy requiring additional evidence
    Ze, Yuyang
    Zhang, Xiaowen
    Shao, Fei
    Zhu, Lin
    Shen, Shanmei
    Zhu, Dalong
    Bi, Yan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) : 2751 - 2759
  • [9] Active surveillance of low-risk papillary thyroid microcarcinomas
    Ito, Yasuhiro
    Miyauchi, Akira
    GLAND SURGERY, 2020, 9 (05) : 1663 - 1673
  • [10] Active surveillance of low-risk papillary thyroid microcarcinoma
    Sugitani, Iwao
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (01)